MOLECULAR PREDICTORS OF RESPONSE TO SELINEXOR IN RECURRENT GLIOBLASTOMA (GBM)

被引：0

作者：

Walker, Christopher ^{[1
]}

Shen, Yao ^{[2
]}

Mau-Soerensen, Morten ^{[3
]}

Wen, Patrick ^{[4
]}

van den Bent, Martin ^{[5
]}

Plotkin, Scott ^{[6
]}

Walenkamp, Annemiek ^{[7
]}

Green, Adam ^{[8
]}

Califano, Andrea ^{[2
]}

Chang, Hua ^{[1
]}

Tamir, Sharon ^{[1
]}

Henegar, Leah ^{[1
]}

Shacham, Sharon ^{[1
]}

Alvarez, Mariano ^{[2
]}

Landesman, Yosef ^{[1
]}

Lassman, Andrew ^{[9
]}

机构：

[1] Karyopharm Therapeut Inc, Newton, MA USA

[2] Darwin Hlth, New York, NY USA

[3] Rigshosp, Copenhagen Univ Hosp, Copenhagen, Denmark

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Erasmus MC Canc Inst, Rotterdam, Netherlands

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Univ Groningen, Groningen, Netherlands

[8] Univ Colorado, Aurora, CO USA

[9] Columbia Univ, New York Presbyterian Hosp, Irving Med Ctr, New York, NY USA

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BIOM-26

引用

页码：7 / 7

页数：1

共 50 条

[41] FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
Barkhoudarian, Garni
Badruddoja, Michael
Blondin, Nicholas
Chen, Ricky
Chowdhary, Sajeel
Cobbs, Charles
Dowling, Anthony
Duic, Paul
Flores, John Paul
Fonkem, Ekokobe
McClay, Edward
Nabors, Louis
Salacz, Michael
Vaillant, Brian
Kesari, Santosh
NEURO-ONCOLOGY, 2019, 21 : 29 - 29
[42] A STUDY OF CLINICAL AND MOLECULAR PROGNOSTIC FACTORS FOR RESPONSE TO REGORAFENIB IN RECURRENT GLIOBLASTOMA.
Chiesa, Silvia
Mangraviti, Antonella
Martini, Maurizio
Cenci, Tonia
Mazzarella, Ciro
Gaudino, Simona
Bracci, Serena
Martino, Antonella
Della Pepa, Giuseppe M.
Offi, Martina
Gessi, Marco
Russo, Rosellina
Martucci, Matia
Bartoli, Francesco Beghella
Di Bonaventura, Rina
Larocca, Luigi M.
Lauretti, Liverana
Olivi, Alessandro
Pallini, Roberto
Balducci, Mario
D'Alessandris, Quintino Giorgio
NEURO-ONCOLOGY, 2022, 24 : 12 - 12
[43] REOPERATION IN MOLECULAR SUBTYPES OF RECURRENT GLIOBLASTOMA
Dono, Antonio
Zhu, Ping
Holmes, Emma
Takayasu, Takeshi
Blanco, Angel
Hsu, Sigmund
Bhattacharjee, Meenakshi
Zhu, Jay-Jiguang
Ballester, Leomar Y.
Esquenazi, Yoshua
Tandon, Nitin
NEURO-ONCOLOGY, 2020, 22 : 208 - 208
[44] Regional variations in molecular regulators of angiogenesis in human glioblastoma multiforme (GBM)
Mukherjee, Joydeep
Pandita, Ajay
Guha, Abhijit
CANCER RESEARCH, 2006, 66 (08)
[45] Phase I study of gefitinib and rapamycin in adult patients with recurrent glioblastoma multiforme (GBM).
Phuphanich, Surasak
Chu, Ray
Yu, John S.
Black, Keith L.
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3462S - 3462S
[46] Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
Farasat Kazmi
Yu Yang Soon
Yiat Horng Leong
Wee Yao Koh
Balamurugan Vellayappan
Journal of Neuro-Oncology, 2019, 142 : 79 - 90
[47] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
Shih, Kent C.
Patel, Manish R.
Butowski, Nicholas A.
Bacha, Jeffrey A.
Brown, Dennis
Garner, William J.
Stelno, Anne
Schwartz, Richard Stephen
Kanekal, Sarath
Lopez, Lorena
Burris, Howard A.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[48] PHASE 1 TRIAL OF BEVACIZUMAB PLUS TPI 287 IN ADULTS WITH RECURRENT GLIOBLASTOMA (GBM)
Conrad, Charles
Yung, W. K. Alfred
deGroot, John
Gilbert, Mark
Loghin, Monica
Penas-Prado, Marta
Tremont, Ivo
Silberman, Sandra
Picker, Donald
NEURO-ONCOLOGY, 2013, 15 : 106 - 106
[49] Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
Kazmi, Farasat
Soon, Yu Yang
Leong, Yiat Horng
Koh, Wee Yao
Vellayappan, Balamurugan
JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (01) : 79 - 90
[50] Treatment of recurrent anaplastic astrocytoma (AA) and glioblastoma multiforme (GBM) with the glutamate antagonist riluzole
Das, A
Learn, J
Le, MT
Yu, J
Pikul, B
Black, K
NEURO-ONCOLOGY, 2004, 6 (04) : 373 - 373

← 1 2 3 4 5 →